Banco Bilbao Vizcaya Argentaria, S.A. Vbi Vaccines Inc Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$2.77 - $6.17 $277,000 - $617,000	-100,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$0.73 - $1.91 $73,000 - $191,000	100,000 New	100,000 $338,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.